IQ Consortium

IQ Consortium is a technically-focused organization dedicated to advancing science-based and scientifically-driven standards and regulations for pharmaceutical and biotechnology products worldwide. Operating as an international consortium for innovation and quality in pharmaceutical development, IQ Consortium provides a sustained forum for the exchange of ideas within and across technical disciplines in these industries. The consortium’s work enhances the quality and safety of pharmaceutical manufacturing on a global scale.

Based in Washington, D.C., US, IQ Consortium leads initiatives in critical areas such as chemistry, manufacturing and control, preclinical safety, drug metabolism, clinical pharmacology, and quality. Through collaborative research, industry surveys, and benchmarking exercises, members actively participate in shaping the future of pharmaceutical and biotechnology standards. IQ Consortium also focuses on the reduction, refinement, and replacement of animal testing, demonstrating a commitment to ethical and innovative practices.

IQ Consortium partners with governmental bodies, trade groups, and academic researchers to share the results of its work through publications, scientific conferences, workshops, and roundtables. The organization's commitment to constructive scientific exchange ensures the continuous improvement and advancement of pharmaceutical and biotechnology products. We invite the management team at IQ Consortium to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions.